Health Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1 Eli Pacheco Apr 15, 2022 0 Intratumoral injection of an investigational agent, BO-112, combined with pembrolizumab (Keytruda) demonstrated promising efficacy in…
